Centene Corp Files 8-K for Regulation FD Disclosure

Ticker: CNC · Form: 8-K · Filed: 2024-09-16T00:00:00.000Z

Sentiment: neutral

Topics: regulation-fd, disclosure

TL;DR

Centene filed an 8-K for a Reg FD disclosure on 9/16/24.

AI Summary

Centene Corporation filed an 8-K on September 16, 2024, to report a Regulation FD Disclosure. The filing does not contain specific details about the nature of the disclosure, dollar amounts, or dates beyond the filing date itself.

Why It Matters

This filing indicates Centene Corporation is making a public disclosure under Regulation FD, which requires companies to share material information broadly.

Risk Assessment

Risk Level: low — The filing is a standard procedural disclosure without immediate financial implications.

Key Numbers

Key Players & Entities

FAQ

What specific information is being disclosed under Regulation FD?

The filing does not specify the content of the Regulation FD disclosure, only that it is being made.

When was the earliest event reported in this 8-K?

The earliest event reported is September 16, 2024.

What is Centene Corporation's principal executive office address?

Centene Corporation's principal executive offices are located at 7700 Forsyth Boulevard, St. Louis, Missouri 63105.

What is the company's state of incorporation?

Centene Corporation is incorporated in Delaware.

What is the purpose of this Form 8-K filing?

The purpose of this Form 8-K filing is to report a Regulation FD Disclosure.

From the Filing

0001071739-24-000172.txt : 20240916 0001071739-24-000172.hdr.sgml : 20240916 20240916162928 ACCESSION NUMBER: 0001071739-24-000172 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 13 CONFORMED PERIOD OF REPORT: 20240916 ITEM INFORMATION: Regulation FD Disclosure FILED AS OF DATE: 20240916 DATE AS OF CHANGE: 20240916 FILER: COMPANY DATA: COMPANY CONFORMED NAME: CENTENE CORP CENTRAL INDEX KEY: 0001071739 STANDARD INDUSTRIAL CLASSIFICATION: HOSPITAL & MEDICAL SERVICE PLANS [6324] ORGANIZATION NAME: 02 Finance IRS NUMBER: 041406317 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-31826 FILM NUMBER: 241301414 BUSINESS ADDRESS: STREET 1: 7700 FORSYTH BLVD. CITY: ST LOUIS STATE: MO ZIP: 63105 BUSINESS PHONE: 3147254477 MAIL ADDRESS: STREET 1: 7700 FORSYTH BLVD. CITY: ST LOUIS STATE: MO ZIP: 63105 8-K 1 cnc-20240916.htm 8-K cnc-20240916 0001071739 false 0001071739 2024-09-16 2024-09-16 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 16, 2024 CENTENE CORPORATION (Exact Name of Registrant as Specified in Charter) Delaware 001-31826 42-1406317 (State or Other Jurisdiction of Incorporation) (Commission File Number) (IRS Employer Identification No.) 7700 Forsyth Boulevard, St. Louis, Missouri 63105 (Address of Principal Executive Offices) (Zip Code) Registrant's telephone number, including area code: ( 314 ) 725-4477 (Former Name or Former Address, if Changed Since Last Report): N/A Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below): ☐      Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) ☐      Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) ☐      Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) ☐      Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Title of each class Trading Symbol(s) Name of each exchange on which registered Common stock, $0.001 Par Value CNC New York Stock Exchange Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).   Emerging growth company  ☐   If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ☐ ITEM 7.01 REGULATION FD DISCLOSURE The Company will meet with investors on Tuesday, Sept. 17, 2024 and present at the Bank of America 2024 Global Healthcare Conference in London on Wednesday, Sept. 18, 2024, which will be webcast at https://bofa.veracast.com/webcasts/bofa/globalhealthcareuk2024/x1aRN0.cfm at 5:50 am EDT /10:50 am BST. In both instances, the Company expects to reaffirm the 2024 full year adjusted diluted earnings per share (EPS) guidance of greater than $6.80. Non-GAAP Financial Presentation The Company is providing certain non-GAAP financial measures in this release as the Company believes that these figures are helpful in allowing investors to more accurately assess the ongoing nature of the Company's operations and measure the Company's performance more consistently across periods. The Company uses the presented non-GAAP financial measure

View on Read The Filing